Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China

BACKGROUND: Hepatitis B surface antigen clearance or seroconversion is rarely achieved for patients using nucleoside analogs or pegylated interferon alpha monotherapy approaches. Several recent studies have confirmed the benefit of a combination of these two approaches for selected chronic hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Runqin, Lin, Xiao, Wang, Jing-Yue, Wang, Xiaomo, Lu, Junfeng, Liu, Yali, Cao, Zhenhuan, Ren, Shan, Ma, Lina, Jin, Yi, Zheng, Sujun, Hu, Zhongjie, Wang, Li, Chen, Xinyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506536/
https://www.ncbi.nlm.nih.gov/pubmed/34733917
http://dx.doi.org/10.21037/atm-21-1666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506536/
https://www.ncbi.nlm.nih.gov/pubmed/34733917
http://dx.doi.org/10.21037/atm-21-1666

Ejemplares similares